IKT News

Four IPOs are scheduled to raise $1.8 billion in the shortened holiday week, featuring a diverse group of foreign issuers.   China’s leading e-cigarette brand RLX Technology (RLX) plans to raise $1.0 billion at a $14.0 billion market cap. RLX Technology sells e-cigarettes and related accessories through over 100,000 retail outlets throughout China....read more

Inhibikase Therapeutics, an early stage biotech developing kinase inhibitors for Parkinson's and related disorders, raised $18 million by offering 1.8 million shares at $10, the low end of the range of $10 to $12. The company originally filed in July 2020 but postponed in November. It most recently planned to offer 1.4 million shares. At pricing, Inhibikase commands a fully diluted...read more

Eight SPACs went public this past week but no IPOs, as all three scheduled deals postponed or withdrew. New filing activity picked up, led by long-awaited delivery service unicorn DoorDash (DASH), and several launches indicate increased activity in the coming weeks. Three biotech IPOs were scheduled to go public this past week but didn’t make it to...read more

Inhibikase Therapeutics, an early stage biotech developing kinase inhibitors for Parkinson's and related disorders, postponed its IPO on Friday. It had planned to raise $15 million by offering 1.4 million shares at a price range of $10 to $12. The Atlanta, GA-based company was founded in 2008 and booked $1 million in grant revenue for the 12 months ended June 30, 2020. It had...read more